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GENETIC DISORDERS – DEVELOPMENT
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Decreased sulfotransferase SULT1C2 gene expression in DPT- disease of the human kidney, and is one of the major
induced polycystic kidney. causes of chronic renal failure. Two different genes (PKD1
Background. The pathogenesis of polycystic kidney disease and PKD2) have been cloned that are associated with(PKD) remains unclear despite the identification of the genes
mutations causing human ADPKD, and at least one moreresponsible for hereditary PKD. In this study, we investigated
gene for ADPKD is known to exist. Concerning autoso-the alteration of gene expressions in an acquired PKD model
induced by 2-amino-4,5-diphenylthiazole (DPT) using the dif- mal recessive PKD, Tg737 has been cloned in the mouse
ferential display method. model (orpk mouse). Although the protein products
Methods. Kidney mRNA from a Sprague-Dawley rat fed (polycystins) of PKD1 and -2 are considered to be mem-with 1% DPT for 4 days and from a control rat was compared
brane proteins and interact together, their functions andby the RT-PCR differential display method. Differentially ex-
the pathogenic mechanism involving PKD remain un-pressed bands were re-amplified and subcloned. Using these
subclones as probes, the changes in gene expressions were known [1, 2]. Multiple factors are thought to involve
confirmed by Northern blot analysis. Subsequently, mouse kid- the pathogenesis of PKD, including cell proliferation,
ney cDNA library was screened. alterations in tubular transport function, and abnormal-Results. The isolated 1.5-kb cDNA contained an open read-
ity in extracellular matrix and the tubular basementing frame encoding 296 amino acids, which shared 94.3% iden-
membrane [1, 3].tity with rat SULT1C2 sulfotransferase, and was considered to
be its mouse ortholog (GenBank Accession No. AY005469). An acquired form of PKD is induced by feeding of
Mouse SULT1C2 mRNA was abundant in the kidney and stom- 2-amino-4,5-diphenylthiazole (DPT) or its hydroxylated
ach among normal mouse tissues. The expression of SULT1C2 metabolite, 2-amino-4-(4-hydroxyphenyl)-5-phenylthia-mRNA was decreased in the rat kidney after DPT feeding but
zole (Phenol II) to rats. In this model, it has been shownnot in the stomach. Mouse SULT1C2 was expressed successfully
that cyst formation occurs in tandem with basement mem-using pET plasmid vector and E. coli. The recombinant 34-kD
protein was capable of catalyzing the sulfation of p-nitrophenol brane structural changes [4], which precedes changes in
at a Km of 3.1 mmol/L, by utilizing 3-phosphoadenosine 5-phos- cell proliferation and abnormal localization of Na,K-
phosulfate (PAPS) as the sulfate donor. ATPase in tubular epithelial cells [5, 6]. Basement mem-Conclusions. Although the physiological substrate and func-
brane changes are characterized by thickening and com-tion of SULT1C2 have yet to be elucidated, its down-regulation
ponent changes including decrease of sulfated proteogly-could be involved in the cystic changes of tubules by decreasing
the sulfation of the tubular basement membrane components. cans, which is attributed to decreased de novo synthesis
[7, 8]. These observations strongly suggest that altered
synthesis of tubular basement membrane occurs early in
Polycystic kidney disease (PKD) comprises a group of the cascade of events leading to cyst development and
disorders characterized by the growth of numerous cysts plays a critical role in cystic change. Although enzymatic
from the renal tubuli and collecting ducts. Autosomal dom- studies revealed the altered activity of several enzymes
inant PKD (ADPKD) is the most common hereditary [9, 10], the molecular mechanisms for basement mem-
brane changes are still unknown.
The present study examined the changes in gene ex-Key words: polycystic kidney disease, 2-amino-4,5-diphenylthiazole,
DPT, SULT1C2 sulfotransferase. pressions in the rat kidney after DPT administration by
the differential display (DD) method. One gene showingReceived for publication January 18, 2002
reduced expression was SULT1C2, an isoform of the sul-and in revised form March 25, 2002
Accepted for publication April 10, 2002 fotransferase family that may be related to the sulfation
of extracellular matrix components. 2002 by the International Society of Nephrology
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METHODS temperature for 10 minutes three times, followed by
0.1  SSC, 0.1% SDS at 50C for 20 minutes twice. AfterExperimental animals
autoradiography using a Bioimaging Analyzer BAS-2500
In order to induce PKD, 4-week-old male Sprague- (Fuji Film, Tokyo, Japan), the probe was removed by
Dawley rats were fed a diet containing 1%(W/W) DPT washing with 0.5% SDS at 100C for 10 minutes, and the
(Baxter Healthcare Co., Round Lake, IL, USA) ad libi- control analysis was performed using a glyceraldehyde-
tum. For DD, two sibling rats were used as a PKD rat 3-phosphate dehydrogenase (G3PDH) cDNA probe.
and the control. For the experiment of SULT1C2 mRNA tissue distri-
bution, a mouse poly A RNA (2 g) blotted membraneDifferential display
(OriGene, Rockville, MD, USA) was used.
Total RNA was isolated from a PKD rat kidney after
DPT administration for four days and the control rat cDNA library screening
kidney, and was treated with DNase (SV Total RNA Iso- The cNDA library was constructed from a 129Ter/Sv
lation Kit; Promega, Madison, WI, USA). After reverse mouse kidney mRNA (5 g) using the ZAP II cDNA
transcription (RT) by oligo-dT primer (TrueScript II; Sa- synthesis kit and Gigapack III Gold (Stratagene) ac-
wady Technology, Tokyo, Japan), arbitrary primed poly- cording to the manufacturer’s instructions.
merase chain reaction (PCR) was done with oligo-dT Using the subclone from DD as a probe, the cDNA
primer (5-CATTATGCTGAGTGATATCTTTTTTTT library screening was done. Replica filters (Hybond-N;
TNN-3) and arbitrary primers. The arbitrary primer Amersham) were alkali-denatured and fixed by an ultra-
that resulted in a different band of PCR product was a violet (UV) cross-linker (Stratagene). The probe was
mixture of 5-CGGGAAGCTTGCATGGTAGTCT-3 32P-labeled using a Random Primer Labeling Kit (Strata-
and 5-CGGGAAGCTTGTGTTGCACCAT-3. Ther- gene). Hybridization was performed in 50% formamide,
mocycle conditions were: one cycle of five minutes at 0.8 mol/L NaCl, 20 mmol/L Pipes (pH 6.5), 0.5% SDS
80C and one minute at 90C; three cycles of 10 seconds and 0.1 mg/mL salmon sperm DNA at 42C overnight.
at 95C, five minutes at 40C and five minutes at 68C; The filters were washed twice with 0.2  SSC, 0.1%
and 22 cycles of 5 seconds at 95C, 5 seconds at 60C SDS at 60C for 20 minutes. After autoradiography, the
and two minutes at 68C. The PCR products were sepa- positive clones were isolated and subjected to the sec-
rated by a 5% denaturing polyacrylamide gel electropho- ondary screening.
resis (PAGE), stained with Vistra Green (Amersham In vivo excision was done using ExAssist Helper Phage
Pharmacia Biotech, Buckinghamshire, UK), and ana- (Stratagene), and pBluescript SK plasmid DNA was ob-
lyzed with Image QuaNT (Molecular Dynamics, Sunny- tained by transforming SOLR cells by excised phagemid.
vale, CA, USA). DNA sequence was done by the BigDye Terminator
After reconfirmation by another electrophoresis, dif- Cycle Sequencing FS Reaction Ready Kit (PE Applied
ferentially expressed bands were excised from the gel, Biosystems, Foster City, CA, USA) and the ABI PRISM
eluted and re-amplified by PCR under the conditions of 377 DNA Sequencing System (PE Applied Biosystems).
one minute at 90C and 30 cycles of 5 seconds at 95C,
Synthesis of recombinant protein5 seconds at 60C and two minutes at 68C. Re-amplified
PCR products were subcloned by ligation into pGEM-T The open reading frame (ORF) of mouse SULT1C2
vector (Promega), sequenced, and used as a probe for was amplified by PCR and inserted into pET-17b vec-
Northern blot analysis and for cDNA library screening. tor (Novagen, Madison, WI, USA). The PCR primers were
5-ATACATATGGCCTTGACCCCAGAACTGA-3
Northern blot analysis (sense) and 5-TTAAAGCTTAGTGATGGTGATGG
To confirm the differential expression of the gene sus- TGGAGTTCCATGGAGAAGTTCAG-3 (antisense),
pected by DD, Northern blot analysis was performed designed to have the Nde I site and the initiation codon
using the subcloned PCR product probe. Total RNA in the sense primer and Hind III site and five histidine
(20 g) was electrophoresed in a denatured 1% agarose residues for the purification using Ni2-NTA agarose
gel, blotted onto a nylon membrane (Hybond-N; Amer- chromatography in the antisense primer.
sham) and fixed using UV cross-linker (Stratagene, La DH5 competent cells were transformed. After the
Jolla, CA, USA). The probes were labeled with [-32P]- pre-culture at 37C until A600 reached 0.3, the expression
dCTP by the Random Primer Labeling Kit (Stratagene). of the recombinant protein was induced by adding iso-
Prehybridization and hybridization were performed at propyl-	-D-thiogalactopyranoside (IPTG) to 0.1 mmol/L
68C for 30 and 60 minutes, respectively, using Ex- final concentration, followed by overnight culture at 30C.
pressHyb (Clontech Laboratories, Palo Alto, CA, USA). The recombinant protein was purified by Ni2-NTA
The blots were washed with 2  standard sodium citrate agarose chromatography [11] and its molecular size was
checked by SDS-PAGE.(SSC), 0.05% sodium dodecyl sulfate (SDS) at room
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ogy search in the EMBL/GenBank databases using the
BLAST Server showed that the deduced 296 amino acid
sequence was 94.3% identical to rat SULT1C2 sulfotran-
sferase (Table 1), and we termed this cDNA mouse
SULT1C2. The nucleotide sequence of PCR product
used as a probe corresponded to nucleotides 741-988 of
mouse SULT1C2 with 91.1% identity and was 98.8%
identical to rat SULT1C2.
The mouse SULT1C2 cDNA insert was used as a
probe in Northern blot analysis for the tissue distribution
study in a normal mouse and for the study in DPT-
induced PKD rats. Northern blot analysis showed that
SULT1C2 mRNA was abundant only in the kidney and
stomach (Fig. 3). In the DPT-induced PKD rats, the
expression of SULT1C2 mRNA was decreased signifi-
Fig. 1. Representative photomicrograph (hematoxylin and eosin stain, cantly in the kidney, while there was no change in the
corticomedullary junction) of a polycystic kidney induced by feeding
stomach (Figs. 4 and 5).of 1% 2-amino-4,5-diphenylthiazole (DPT) to Sprague-Dawley (SD)
rats for two weeks. By a prokaryotic pET expression system, the recombi-
nant mouse SULT1C2 having five histidine residues at
the C-terminal (SULT1C2-His), was successfully ex-
Measurement of sulfotransferase activity pressed and purified by Ni2-NTA agarose column. The
recombinant protein was at the predicted size, 34 kD,The enzymatic activity of the recombinant protein was
on SDS-PAGE (Fig. 6). Using this purified SULT1C2-His,measured by a modified procedure of Foldes and Meek
we examined its enzymatic properties. Among p-nitro-[12, 13], utilizing 3-phosphoadenosine 5-phosphosul-
phenol, dopamine, 2-naphthol and DPT tested, the re-fate (PAPS) as the sulfate donor. The reaction mixture
combinant protein catalyzed the sulfonation of p-nitro-(200 L) contained 20 mmol/L potassium phosphate
phenol at a Michaelis constant (Km) of 3.1 mmol/L andbuffer (pH 7.0), 0.22 to 6.60 mol/L [35S]PAPS (1.95 Ci/
maximum velocity (Vmax) of 20 nmol/min/mg (Fig. 7), butmmol; New England Nuclear, Boston MA, USA) and
not dopamine, 2-naphthol or DPT.the substrate (a sulfate acceptor). p-nitrophenol, dopa-
mine, 2-naphthol and DPT were tested as the substrate.
The reaction was initiated by adding 10 g of purified DISCUSSION
protein. After incubation at 37C for 15 minutes, the
Using differential display (DD), one gene was identi-reaction was stopped by adding 0.1 mL of ice-cold 0.1
fied that had a decreased expression after DPT admin-mol/L barium acetate. Then, unconverted [35S]PAPS was
istration. The clone we isolated from a mouse kidneyprecipitated by the addition of 0.1 mL each of 0.1 mol/L
cDNA library was most likely SULT1C2, based on itsBa(OH)2 and 0.1 mol/L ZnSO4, and the precipitation
high homology. Although a rat library should have beenwas removed by centrifugation. After the precipitation
screened, we used a mouse library for the possibility ofprocedure was repeated, the radioactivity of the superna-
producing the knockout mouse.tant was measured by a liquid scintillation counter.
Sulfotransferases have a variety of biological roles by
catalyzing the transfer of the sulfonate moiety from PAPS
RESULTS to many substrates. Two distinct families, namely cyto-
solic sulfotransferases and membrane-bound sulfotrans-Polycystic kidney disease was induced in the rat kidney
ferases localized in the Golgi apparatus, have been iden-by DPT administration for two weeks, and this was dem-
onstrated microscopically (Fig. 1). tified, and each is subdivided into several families based
on their amino acid sequence homology and substrateAlthough six candidate bands were recognized by DD
using 10 different sets of arbitrary primers, the differen- specificities [14–16]. Cytosolic sulfotransferases are gen-
erally associated with the metabolism of xenobiotics andtial gene expression of only one candidate clone was
confirmed by Northern blot analysis (data not shown). small endogenous compounds, and membrane-bound sul-
fotransferases generally catalyze the sulfation of proteins,By mouse kidney cDNA library screening using this sub-
cloned probe, we obtained a plasmid containing an insert peptides and glycosaminoglycans. SULT1C2 was first
cloned from a rabbit stomach cDNA library as a memberof 1482 bp. Sequencing of the insert revealed an ORF
of 891 bp flanked by 209 bp of 5 untranslated region of cytosolic sulfotransferases [17]. Human [17, 18] and
rat [19] SULT1C2 also have been cloned, and SULT1C2(UTR) and 382 bp of 3 UTR containing a poly A tail
(Fig. 2; GenBank Accession No. AY005469). A homol- mRNA was most abundant in kidney, followed by stom-
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Fig. 2. Nucleotide sequence of the mouse SULT1C2 cDNA and the predicted amino acid sequence. The accession number of this cDNA in the
GenBank is AY005469.
Table 1. Amino acid sequence identities of mouse SULT1C2
with selected sulfotransferase family members
Sequence
GenBank size of
accession amino acid Sequence
SULT isoform number residues identity %
Mouse SULT1C2 AY005469 296 100
Rat SULT1C2 AJ238391 296 94.3
Rat SULT1C2A AJ238392 296 89.5
Rabbit SULT1C2 AF026304 296 79.4
Human SULT1C2 AF186263 302 61.6 Fig. 3. Northern blot analysis of mouse SULT1C2 mRNA in various
Phenol SULT adult tissues. Northern blot with poly(A) RNA from brain (lane 1),
Rat SULT1A1 X52883 291 55.1 heart (2), kidney (3), liver (4), lung (5), muscle (6), skin (7), small
Rat SULT1B1 U38419 299 50.7 intestine (8), spleen (9), stomach (10), testis (11) and thymus (12) was
Rat SULT1C1 L22339 304 59.5 hybridized with 32P-labeled mouse SULT1C2 cDNA probe. The sameRat SULT1E2 M86758 295 47.0 membrane was hybridized with mouse G3PDH cDNA. Each lane con-Hydroxysteroid SULT
tained 2 g of poly(A) RNA.Rat SULT20/21 M31363 284 37.4
Rat SULT40/41 M33329 284 38.4
Rat SULT60 D14989 285 40.4
activity utilizing PAPS as a sulfate donor and p-nitrophe-
nol as a substrate [17, 19]. However, the physiological
ach and liver in rats [19], which is consistent with our substrate of SULT1C2 is still questionable because of
results in mice except that liver mRNA was not detect- the low affinity to p-nitrophenol. In both their and our
able in our study. Enzymatic studies of the recombinant current experiments, the Km measured toward p-nitrophe-
nol was at the order of mmol/L [17, 19], in contrast withSULT1C2 proteins demonstrated the sulfotransferase
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Fig. 4. Northern blot analysis of SULT1C2
mRNA in rat kidneys after DPT feeding. Kid-
neys were obtained from SD rats fed with 1%
DPT for 1, 2, 4 and 14 days. Each lane was
loaded with sample from one rat, and two sets
of days 0 to 4 shown are from a different series
of the experiments. The same membranes
were hybridized with mouse G3PDH cDNA.
Each lane contained 20 g of total RNA.
Fig. 5. Quantitative analysis of SULT1C2 mRNA in rat kidney and
stomach after DPT feeding for one week. Northern blot analysis was
done as described in the Methods section, and the signals quantified
by a Bioimaging Analyzer were normalized with G3PDH. The mean
ratio of control rats was taken as 100%.
Fig. 6. SDS-PAGE of recombinant SULT1C2-His. SULT1C2-His was
expressed as described in the Methods section, and purified by Ni2-SULT1A1, which preferentially catalyzed this reaction
NTA agarose chromatography. Lane 1; flow through from Ni2-NTAat a Km below mol/L [15]. Thus, the physiological func- agarose column. Lane 2; purified SULT1C2-His.
tions of SULT1C2 are unclear, and to our knowledge
the present study is the first report concerning the change
in SULT1C2 gene expression. plain the mechanism for down-regulation of SULT1C2
The possibility that SULT1C2 is involved in the me- mRNA in the kidney by DPT administration.
tabolism and excretion of DPT increases when consider- As to the relationship between SULT1C2 mRNA
ing that sulfation of xenobiotics is one of the biological down-regulation and the cystic change of the kidney, we
roles of cytosolic sulfotransferases. However, DPT itself speculate that reduced sulfotransferase activity may re-
was not shown to be a substrate for SULT1C2, though sult in abnormal synthesis of extracellular matrix compo-
there are no data about DPT metabolites. If SULT1C2 nents. In DPT-induced PKD, the incorporation of [35S]sul-
participates in DPT metabolism, SULT1C2 expression fate into proteoglycans was shown to decrease in the
should be increased in response to the increased sub- perfused kidney [7], which is consistent with this specu-
lation. As decreased synthesis of sulfated glycoproteinsstrate concentration. At present, we have no data to ex-
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Fig. 7. Kinetic analysis of sulfotransferase ac-
tivity to p-nitrophenol by purified recombi-
nant SULT1C2-His. (A) Plot of reaction ve-
locity versus p-nitrophenol concentration as
a substrate. (B) A Lineweaver-Burk double
reciprocal plot of the data was used to deter-
mine the Km (3.1 mmol/L) and Vmax (20 nmol/
min · mg).
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